Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Democrats and Republicans both think it is important that the U.S. is a world leader in science, but most Democrats now think it is losing ground compared with other countries. Fresh data delivered ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback